Carbapenem Breakpoints for Acinetobacter baumannii Group: Supporting Clinical Outcome Data from Patients with Bacteremia

The carbapenem breakpoints set by different organizations for Acinetobacter are discordant, but supporting clinical data are lacking. This study aimed to provide the first clinical outcome data to support the carbapenem breakpoints for Acinetobacter baumannii (Ab) group in patients with bacteremia....

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yi-Tzu, Chiang, Mei-Chun, Kuo, Shu-Chen, Wang, Yung-Chih, Lee, I-Hsin, Chen, Te-Li, Yang, Ya-Sung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028070/
https://www.ncbi.nlm.nih.gov/pubmed/27644087
http://dx.doi.org/10.1371/journal.pone.0163271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028070/
https://www.ncbi.nlm.nih.gov/pubmed/27644087
http://dx.doi.org/10.1371/journal.pone.0163271

Ejemplares similares